Beclabuvir

Star0

DB12225InvestigationalSmall molecule

Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

Mechanism: Pharmacologically active on RNA-directed RNA polymerase
Curator reviewed
Formula / weight: C₃₆H₄₅N₅O₅S · 659.838 g/mol (avg)
Code names: Bms 791325

Resolves to

Compound

UNIIMYW1X5CO9SCAS958002-33-0ChEMBLCHEMBL4105584PubChem56934415

Clinical / RWD

ATCJ05AP58

Structure

InChIKeyZTTKEBYSXUCBSE-QDFUAKMASA-NSMILESCOC1=CC=C2C3=C(C4CCCCC4)C4=CC=C(C=C4N3C[C@]3(C[C@H]3C2=C1)C(=O)N1[C@H]2CC[C@@H]1CN(C)C2)C(=O)NS(=O)(=O)N(C)C

Targets

O39930NS5bP26664Genome polyprotein

What you can answer from here — as of September 20, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Drug interactionsStructured to mechanism, not free text

14Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 6 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Beclabuvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account